Diabetes treatment for solid formulations

The present invention teneligliptin or its pharmaceutically acceptable salts, contain and CANAGLIFLOZIN or salt thereof pharmaceutically acceptable, regardless of the manufacturing lot of the drug substance, excellent storage stability solid preparation an object of the present invention is to provide a. And teneligliptin or moiety containing a pharmaceutically acceptable salt thereof, a solid preparation obtained by mixing the CANAGLIFLOZIN or moiety containing a pharmaceutically acceptable salt thereof, Teneligliptin or solid preparation and salts their pharmaceutically acceptable, characterized in that the CANAGLIFLOZIN or a pharmaceutically acceptable salt thereof is present independently in the formulation so as not substantially contact one another .